Details about the neuroanatomical projections from ORBm to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91777 | Orbital area medial part | Perirhinal area | strong | biotinylated dextran amine (BDA) | The injection resulted in a dense plexus of labeled axons and axonal varicosities rostrally in PER, at the level where the dorsal hippocampus merges with the ventral hippocampus. Collator note: strong labeling in the rostral PERI, especially in layer V, with some label in layers II-III. See Fig. 4B, Swanson Atlas Levels 31-33. | Kondo H. & Witter M.P., 2014 | |
| 91779 | Orbital area medial part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | The labeling density decreased at more rostral levels (Fig. 4A) and at more caudal levels of PER (Fig. 4C,D). Collator note: weak-moderate label in the rostralmost part of the ECT. See Fig. 4A, Swanson Atlas Levels 31-32. | Kondo H. & Witter M.P., 2014 | |
| 91781 | Orbital area medial part | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeled fibers mostly in layer V, mid-rostrocaudally. See Fig. 4C, Swanson Atlas Levels 38-39. | Kondo H. & Witter M.P., 2014 | |
| 91783 | Orbital area medial part | Perirhinal area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal PERI and ECT. See Fig. 4D, Swanson Atlas Levels 41-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-25), the BDA injection involved mainly layer III, with some involvement of layers II and V, at a midrostrocaudal level of MO (Figs. 2, 3A, 4, Table 2). Collator note: the injection is mapped here onto Swanson Atlas Levels 4-5. |
Further details associated to record number 91781:
|
|
|---|
